-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
LAVA Therapeutics NV quarterly and annual Operating Income (Loss) history and change rate from 2023 to Q3 2025.
- LAVA Therapeutics NV Operating Income (Loss) for the quarter ending 30 Sep 2025 was $-7,553,000, a 33.4% increase year-over-year.
- LAVA Therapeutics NV Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $-29,354,000.
- LAVA Therapeutics NV annual Operating Income (Loss) for 2024 was $-29,693,000, a 31.6% increase from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)